Cargando…

PCSK6: The Endogenous PAR-1 Agonist Driving Pulmonary Fibrosis?

Detalles Bibliográficos
Autores principales:	Spek, C. Arnold, Duitman, JanWillem
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Thoracic Society 2023
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10273102/ https://www.ncbi.nlm.nih.gov/pubmed/36927336 http://dx.doi.org/10.1164/rccm.202303-0355LE

Ejemplares similares

Is idiopathic pulmonary fibrosis a cancer-like disease? Transcriptome analysis to fuel the debate
por: Spek, C. Arnold, et al.
Publicado: (2019)

Immune Checkpoints as Promising Targets for the Treatment of Idiopathic Pulmonary Fibrosis?
por: Duitman, JanWillem, et al.
Publicado: (2019)

Macrophage C/EBPδ Drives Gemcitabine, but Not 5-FU or Paclitaxel, Resistance of Pancreatic Cancer Cells in a Deoxycytidine-Dependent Manner
por: Spek, C. Arnold, et al.
Publicado: (2022)

Myeloid DNA methyltransferase3b deficiency aggravates pulmonary fibrosis by enhancing profibrotic macrophage activation
por: Qin, Wanhai, et al.
Publicado: (2022)

Plasmin reduces fibronectin deposition by mesangial cells in a protease-activated receptor-1 independent manner
por: Waasdorp, Maaike, et al.
Publicado: (2017)

Protease‐activated receptor‐1 contributes to renal injury and interstitial fibrosis during chronic obstructive nephropathy
por: Waasdorp, Maaike, et al.
Publicado: (2018)

Protease-activated receptor-1 deficiency protects against streptozotocin-induced diabetic nephropathy in mice
por: Waasdorp, Maaike, et al.
Publicado: (2016)

CCAAT/enhancer binding protein delta (C/EBPδ) deficiency does not affect bleomycin-induced pulmonary fibrosis
por: JanWillem, Duitman, et al.
Publicado: (2018)

Vorapaxar treatment reduces mesangial expansion in streptozotocin-induced diabetic nephropathy in mice
por: Waasdorp, Maaike, et al.
Publicado: (2018)

Matrix Metalloproteases in Pancreatic Ductal Adenocarcinoma: Key Drivers of Disease Progression?
por: Slapak, Etienne J., et al.
Publicado: (2020)

Protease-activated receptor (PAR)-2 is required for PAR-1 signalling in pulmonary fibrosis
por: Lin, Cong, et al.
Publicado: (2015)

Non-Tumor CCAAT/Enhancer-Binding Protein Delta Potentiates Tumor Cell Extravasation and Pancreatic Cancer Metastasis Formation
por: Duitman, JanWillem, et al.
Publicado: (2021)

CEBPD Potentiates the Macrophage Inflammatory Response but CEBPD Knock-Out Macrophages Fail to Identify CEBPD-Dependent Pro-Inflammatory Transcriptional Programs
por: Spek, C. Arnold, et al.
Publicado: (2021)

PCSK6 and Survival in Idiopathic Pulmonary Fibrosis
por: Oldham, Justin M., et al.
Publicado: (2023)

C/EBP-Family Redundancy Determines Patient Survival and Lymph Node Involvement in PDAC
por: Hartl, Leonie, et al.
Publicado: (2023)

Detrimental role for CCAAT/enhancer binding protein δ in blood-borne brain infection
por: Duitman, JanWillem, et al.
Publicado: (2016)

Time-dependent bias when analysing COVID-19-associated pulmonary aspergillosis
por: de Brabander, Justin, et al.
Publicado: (2022)

Structures of adenosine receptor A(2B)R bound to endogenous and synthetic agonists
por: Cai, Hongmin, et al.
Publicado: (2022)

CCAAT/enhancer-binding protein δ (C/EBPδ) aggravates inflammation and bacterial dissemination during pneumococcal meningitis
por: Serón, Mercedes Valls, et al.
Publicado: (2015)

C/EBPδ Suppresses Motility-Associated Gene Signatures and Reduces PDAC Cell Migration
por: Hartl, Leonie, et al.
Publicado: (2022)

Comment on Idiopathic Pulmonary Fibrosis (an Update) and Progressive Pulmonary Fibrosis in Adults
por: Scholand, Mary Beth, et al.
Publicado: (2022)

Isoniazid and Pulmonary Fibrosis
por: Chung, Chae Uk, et al.
Publicado: (2015)

High endogenous activated protein C levels attenuates bleomycin‐induced pulmonary fibrosis
por: Lin, Cong, et al.
Publicado: (2016)

Novel Insight into Pulmonary Fibrosis and Long COVID
por: Kamp, Jan C., et al.
Publicado: (2023)

Postvaccination Acute Exacerbations of Idiopathic Pulmonary Fibrosis?
por: Huang, Jin-Xian, et al.
Publicado: (2022)

Randomized Phase IIa Clinical Study of an Anti-α(v)β(6) Monoclonal Antibody in Idiopathic Pulmonary Fibrosis
por: Raghu, Ganesh, et al.
Publicado: (2022)

Progressive Pulmonary Fibrosis: Putting the Cart Before the Horse
por: Johannson, Kerri A., et al.
Publicado: (2022)

Reply: Transitioning endothelial cells contribute to pulmonary fibrosis
por: Wu, Xiuju, et al.
Publicado: (2023)

Maladaptive TGF-β Signals to the Alveolar Epithelium Drive Fibrosis after COVID-19 Infection
por: Yao, Changfu, et al.
Publicado: (2023)

DOT1L-HES6 fusion drives androgen independent growth in prostate cancer
por: Annala, Matti, et al.
Publicado: (2014)

Comparing Transbronchial Cryobiopsy and Surgical Biopsy in Idiopathic Pulmonary Fibrosis
por: Quadrelli, Silvia, et al.
Publicado: (2019)

Comments on COVID-19 Vaccination and Exacerbation of Idiopathic Pulmonary Fibrosis
por: Kang, Tianlun, et al.
Publicado: (2022)

Progressive Pulmonary Fibrosis: Should the Timelines Be Taken Out of the Definition?
por: Cottin, Vincent, et al.
Publicado: (2022)

Progressive Interstitial Lung Disease in Relatives of Patients with Pulmonary Fibrosis
por: Rose, Jonathan A., et al.
Publicado: (2022)

COVID-19 Vaccine in Patients with Exacerbation of Idiopathic Pulmonary Fibrosis
por: Sgalla, Giacomo, et al.
Publicado: (2022)

Targeting Pulmonary Hypertension Caused by Pulmonary Fibrosis: A Promising Natural Killer T Cell–based Therapy
por: Wang, Zi-Hao, et al.
Publicado: (2023)

Patient Registries in Idiopathic Pulmonary Fibrosis: Don't Forget Socioeconomic Status
por: Sesé, Lucile, et al.
Publicado: (2020)

Too Premature to Deny the Potential of Thrombomodulin Alfa in Idiopathic Pulmonary Fibrosis
por: Kobayashi, Tetsu, et al.
Publicado: (2020)

Measurement of hypoxia in the lung in idiopathic pulmonary fibrosis: a matter of control
por: Bellaye, Pierre-Simon, et al.
Publicado: (2022)

Idiopathic Pulmonary Fibrosis Update: Reconciliation with Hypersensitivity Pneumonitis Guidelines Required?
por: Moran-Mendoza, Onofre
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_n6dos79knu9scf13714au8qtc8